Shares of Glenmark Pharmaceuticals Ltd . gained on Thursday, October 23, after the company said its US subsidiary, Glenmark Pharmaceuticals Inc., is set to launch Ropivacaine Hydrochloride Injection USP in the American market.

The product will be available in 40 mg/20 mL (2 mg/mL), 150 mg/30 mL (5 mg/mL), and 200 mg/20 mL (10 mg/mL) single-dose vials.

The injection is bioequivalent and therapeutically equivalent to Naropin injection, manufactured by Fresenius Kabi USA, LLC, Glenmark Pharmaceuticals said.

Ropivacaine injection is used to numb an area of the body before or during surgery or childbirth. It can also be used to relieve sudden or severe pain. The injectable is used as an anaesthetic drug to numb specific areas of the body before or during surgery or childbirth and to reliev

See Full Page